Drug-induced adverse events prediction with the LINCS L1000 data
about
Applications of chemogenomic library screening in drug discoveryl1kdeconv: an R package for peak calling analysis with LINCS L1000 data.Optimizing drug development in oncology by clinical trial simulation: Why and how?Identifying the common genetic networks of ADR (adverse drug reaction) clusters and developing an ADR classification model.Reconstructing cancer drug response networks using multitask learning.Knowledge graph prediction of unknown adverse drug reactions and validation in electronic health records.The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations.EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to Improve Prediction Accuracy.Pharmacogenomics and big genomic data: from lab to clinic and back again.Translating New Science Into the Drug Review Process: The US FDA's Division of Applied Regulatory Science.The relative resistance of children to sepsis mortality: from pathways to drug candidates.A workflow for the integrative transcriptomic description of molecular pathology and the suggestion of normalizing compounds, exemplified by Parkinson's disease.Association Between Serotonin Syndrome and Second-Generation Antipsychotics via Pharmacological Target-Adverse Event Analysis.Sustainable data and metadata management at the BD2K-LINCS Data Coordination and Integration Center.A novel method of using Deep Belief Networks and genetic perturbation data to search for yeast signaling pathways
P2860
Q28656335-1BF6DDDC-6E65-4290-91A4-9EB0349BD5FFQ38657117-41A2AA96-D8DD-46BB-987D-D4E3FEA52CC0Q38675644-EF5E8391-FA56-4772-A5B1-AC2DFAA90D9DQ38681717-C2F92973-4451-4CAA-B8B7-224800C18F3CQ42374512-2F609DD5-6055-4C26-94A2-94D4EA2C66CDQ45943555-9516EE39-4C14-45C9-86FC-132517E8055CQ46954616-12DBC35B-46E7-49BD-9716-72F6A8351033Q52311264-465BB539-2F02-4438-9FFD-B4974D2A9DE6Q52596040-224B1C5D-1A6F-4DB1-BFFE-23735EDD6375Q52641412-84434B63-42E7-4FE2-89D5-0B2857DFAF49Q55032528-4CDF2CB9-43B7-45E5-8620-CB6415640203Q55063113-E66D237D-ECFA-4C80-808C-1AE4D0BD040DQ55308829-61058329-ACB7-420B-AC27-B61D377D97E2Q55345467-F53E2344-35FB-4925-84AC-BC4F6B717F26Q58747881-60FB5CAD-80BA-483E-8920-2F1A4D5F603D
P2860
Drug-induced adverse events prediction with the LINCS L1000 data
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Drug-induced adverse events prediction with the LINCS L1000 data
@ast
Drug-induced adverse events prediction with the LINCS L1000 data
@en
type
label
Drug-induced adverse events prediction with the LINCS L1000 data
@ast
Drug-induced adverse events prediction with the LINCS L1000 data
@en
prefLabel
Drug-induced adverse events prediction with the LINCS L1000 data
@ast
Drug-induced adverse events prediction with the LINCS L1000 data
@en
P2860
P356
P1433
P1476
Drug-induced adverse events prediction with the LINCS L1000 data
@en
P2093
Neil R Clark
P2860
P304
P356
10.1093/BIOINFORMATICS/BTW168
P407
P577
2016-04-01T00:00:00Z